£545K
The funding will support the company as it prepares to launch its CUE1 device in the UK and EU markets.
CN
Charco Neurotech
Charco Neurotech develops medical devices to help manage movement symptoms associated with Parkinson disease.
United Kingdom—Founded 2019
£1.0MTotal raised
Charco Neurotech is a medical technology company developing a vibrotactile stimulation device to help manage symptoms of Parkinson disease.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Charco Neurotech's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Lucy Jung
CEO and Co-founder
Lucy serves as chief executive and co-founder of Charco Neurotech. She also teaches at Oxford Royale and lectures at Imperial College London.
LinkedIn
Floyd Pierres
Co-founder
Floyd is a medical registrar and co-founder at Charco Neurotech, alongside clinical experience within the NHS.
LinkedInInvestors
- £545KCGCrista GalliFollow-on
- £500K
Funding history
£500K
The seed round was led by Parkwalk Advisors and includes backing from Amadeus Capital Partners, Crista Galli, RCA, and Oxbridge Angels to fund the market launch of the CUE1 device.